Allergina inhibits the progression of graft rejection, hypersensitivity, and collagen-induced autoimmune arthritis

  • Lee, C-W (Biopotency Evaluation Laboratory, Korea Research Institute of Bioscience Biotechnology (KRIBB)) ;
  • Han, S-B (Biopotency Evaluation Laboratory, Korea Research Institute of Bioscience Biotechnology (KRIBB)) ;
  • Yoon, P-S (Biopotency Evaluation Laboratory, Korea Research Institute of Bioscience Biotechnology (KRIBB)) ;
  • Jeong, C-M (Biopotency Evaluation Laboratory, Korea Research Institute of Bioscience Biotechnology (KRIBB)) ;
  • Lee, M-L (Biopotency Evaluation Laboratory, Korea Research Institute of Bioscience Biotechnology (KRIBB)) ;
  • Kim, K-M (Biopotency Evaluation Laboratory, Korea Research Institute of Bioscience Biotechnology (KRIBB)) ;
  • Yoon, Y-D (Biopotency Evaluation Laboratory, Korea Research Institute of Bioscience Biotechnology (KRIBB)) ;
  • Kim, H-C (Biopotency Evaluation Laboratory, Korea Research Institute of Bioscience Biotechnology (KRIBB)) ;
  • Park, S-K (Biopotency Evaluation Laboratory, Korea Research Institute of Bioscience Biotechnology (KRIBB))
  • 발행 : 2002.11.01

초록

The herbal combination allergina has been used for the treatment of inflammatory diseases in South Korea. In this study, we investigated the immunosuppressive activities of allergina in more detail. Acute graft-versus-host disease (GVHD) is a major cause of morbidity and mortality in patients undergoing allogeneic bone marrow transplantation.(omitted)

키워드